Connect-One: Early Feasibility Study of Connexus® Brain-Computer Interface (BCI)
Condition(s) studied
Investigational drug(s) / intervention(s)
Connexus Brain-Computer Interface: The Connexus Brain Computer Interface is an implantable brain-computer interface.
Study summary
The Connect-One Study is an early feasibility study to obtain preliminary device safety information for the Connexus Brain-Computer Interface (BCI). The Connexus BCI is intended to be used as: (1) an assistive communication device to decode imagined language correlates and speech for patients with impaired communication as a result of severe loss of voluntary motor control; and (2) to provide control of computer devices for individuals with severe loss of voluntary motor control of the upper extremity.
Eligibility
Primary outcome measure(s)
- Primary Safety: Number of Subjects With Device Related Adverse Events — Up to 12 months post-implant
Device Related Adverse Events: Number of subjects with device-related adverse events
Trial sites (3)
| Facility | City | Region | Status |
|---|---|---|---|
| University of California, Davis | Sacramento | California | Recruiting |
| Massachusetts General Hospital | Boston | Massachusetts | Recruiting |
| University of Michigan | Ann Arbor | Michigan | Recruiting |
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07357428 on ClinicalTrials.gov ↗ ← All trials in the USA